Document is current
Any future updates will be listed below
-
Authors
Veit, Ethan C. https://orcid.org/0000-0002-3956-5928
Salim, Madihah S.
Jung, Mariel J.
Richardson, R. Blake
Boys, Ian N.
Quinlan, Meghan
Barrall, Erika A.
Bednarski, Eva
Hamilton, Rachael E.
Kikawa, Caroline
Elde, Nels C. https://orcid.org/0000-0002-0426-1377
García-Sastre, Adolfo https://orcid.org/0000-0002-6551-1827
Evans, Matthew J. https://orcid.org/0000-0002-4991-3877
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (AI083203, AI007647, AI007647, AI083203)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (GM134936)
- License Information
-
More Information
Article History
Received: 23 January 2024
Accepted: 18 June 2024
First Online: 26 June 2024
Competing interests
: Adolfo García-Sastre has received research support from GSK, Pfizer, Senhwa Biosciences, Kenall Manufacturing, Blade Therapeutics, Avimex, Johnson & Johnson, Dynavax, 7Hills Pharma, Pharmamar, ImmunityBio, Accurius, Nanocomposix, Hexamer, N-fold LLC, Model Medicines, Atea Pharma, Applied Biological Laboratories and Merck, outside of the reported work. A.G.-S. has consulting agreements for the following companies involving cash and/or stock: Castlevax, Amovir, Vivaldi Biosciences, Contrafect, 7Hills Pharma, Avimex, Pagoda, Accurius, Esperovax, Farmak, Applied Biological Laboratories, Pharmamar, CureLab Oncology, CureLab Veterinary, Synairgen, Paratus, Pfizer and Prosetta, outside of the reported work. A.G.-S. has been an invited speaker in meeting events organized by Seqirus, Janssen, Abbott and Astrazeneca. A.G.-S. is inventor on patents and patent applications on the use of antivirals and vaccines for the treatment and prevention of virus infections and cancer, owned by the Icahn School of Medicine at Mount Sinai, New York, outside of the reported work. The remaining authors declare no competing interests.
